These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. NAD(P)H oxidase modulates angiogenesis and the development of portosystemic collaterals and splanchnic hyperaemia in portal hypertensive rats. Angermayr B, Fernandez M, Mejias M, Gracia-Sancho J, Garcia-Pagan JC, Bosch J. Gut; 2007 Apr; 56(4):560-4. PubMed ID: 16854998 [Abstract] [Full Text] [Related]
4. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. Fernandez M, Mejias M, Angermayr B, Garcia-Pagan JC, Rodés J, Bosch J. J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841 [Abstract] [Full Text] [Related]
5. Prehepatic portal hypertension produces increased mast cell density in the small bowel and in mesenteric lymph nodes in the rat. Prieto I, Aller MA, Santamaría L, Nava MP, Madero R, Pérez-Robledo JP, Arias J. J Gastroenterol Hepatol; 2005 Jul; 20(7):1025-31. PubMed ID: 15955210 [Abstract] [Full Text] [Related]
6. Progressive hepatocytic fatty infiltration in rats with prehepatic portal hypertension. Alonso MJ, Aller MA, Corcuera MT, Nava MP, Gömez F, Angulo A, Arias J. Hepatogastroenterology; 2005 Jul; 52(62):541-6. PubMed ID: 15816474 [Abstract] [Full Text] [Related]
7. Prehepatic portal hypertension induces alterations in cytochrome oxidase activity in the rat adrenal gland. López L, Aller MA, Miranda R, Sánchez-Patán F, Nava MP, Arias J, Arias JL. J Invest Surg; 2006 Jul; 19(2):79-86. PubMed ID: 16531365 [Abstract] [Full Text] [Related]
8. [Development of pre-hepatic portal hypertension of the rat]. Aller Reyero MA, Diéguez Fernández B, Nava Hidalgo MP, Cuesta Alvaro P, Sánchez García M, Duran Giménez-Rico HJ, Llamas Matías MA, Arias Pérez J. An Med Interna; 2002 Jul; 19(7):341-51. PubMed ID: 12224142 [Abstract] [Full Text] [Related]
9. [Long-term portal hypertension in the rat by means of triple stenotic ligation of the portal vein]. Rodríguez Fabián G, Monterde García G, Diéguez Fernández B, Aller Reyero MA, Arias Pérez J. An Med Interna; 2000 Mar; 17(3):137-41. PubMed ID: 10804636 [Abstract] [Full Text] [Related]
10. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension. Cao H, Xu J, Liu H, Meng FB, Qiu JF, Wu ZY. Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343 [Abstract] [Full Text] [Related]
11. Prophylaxis with ketotifen in rats with portal hypertension: involvement of mast cell and eicosanoids. Sanchez-Patan F, Anchuelo R, Vara E, Garcia C, Saavedra Y, Vergara P, Cuellar C, Rodero M, Aller MA, Arias J. Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):383-94. PubMed ID: 18693174 [Abstract] [Full Text] [Related]
12. Hepatic cytochrome oxidase in rats with microsurgical cholestasis or portocaval shunt. López L, Begega A, Arias JL, Lorente L, Aller MA, Durán Poveda M, Arias J. Rev Esp Enferm Dig; 1999 May; 91(5):365-73. PubMed ID: 10362878 [Abstract] [Full Text] [Related]
13. [Evaluation of the hemodynamic effects of tumor necrosis factor alpha factor in rats with portal hypertension using the radioactive microsphere technique]. Pérez-Páramo M, Muñoz J, Albillos A, Rossi I, Alvarez-Mon M, Ortiz Berrocal J. Rev Esp Med Nucl; 1998 May; 17(4):294-301. PubMed ID: 9721346 [Abstract] [Full Text] [Related]
14. Increased cytochrome oxidase activity in adrenal glands of thioacetamide-cirrhotic rats. Méndez-López M, Méndez M, López L, Aller MA, González-Pardo H, Nava MP, Sánchez-Patán F, Arias J, Arias JL. Neuro Endocrinol Lett; 2005 Dec; 26(6):719-23. PubMed ID: 16380689 [Abstract] [Full Text] [Related]
15. Partial hepatectomy, partial portal vein stenosis and mesenteric lymphadenectomy increase splanchnic mast cell infiltration in the rat. Moquillaza LM, Aller MA, Nava MP, Santamaría L, Vergara P, Arias J. Acta Histochem; 2010 Jul; 112(4):372-82. PubMed ID: 19446312 [Abstract] [Full Text] [Related]
16. Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension. Coll M, Genescà J, Raurell I, Rodríguez-Vilarrupla A, Mejías M, Otero T, Oria M, Esteban R, Guardia J, Bosch J, Martell M. J Hepatol; 2008 Jul; 49(1):43-51. PubMed ID: 18457899 [Abstract] [Full Text] [Related]
18. Splanchnic cortisol production in dogs occurs primarily in the liver: evidence for substantial hepatic specific 11beta hydroxysteroid dehydrogenase type 1 activity. Basu R, Edgerton DS, Singh RJ, Cherrington A, Rizza RA. Diabetes; 2006 Nov; 55(11):3013-9. PubMed ID: 17065337 [Abstract] [Full Text] [Related]
19. Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state. Abraldes JG, Iwakiri Y, Loureiro-Silva M, Haq O, Sessa WC, Groszmann RJ. Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G980-7. PubMed ID: 16603731 [Abstract] [Full Text] [Related]
20. Mast cell inhibition by ketotifen reduces splanchnic inflammatory response in a portal hypertension model in rats. Sánchez-Patán F, Aller MA, Cuellar C, Rodero M, Corcuera MT, Nava MP, Gómez F, Blanco MD, Guerrero S, Anchuelo R, Muñiz E, Alonso MJ, Teijón JM, Arias J. Exp Toxicol Pathol; 2008 Aug; 60(4-5):347-55. PubMed ID: 18514499 [Abstract] [Full Text] [Related] Page: [Next] [New Search]